Publications by authors named "Angelo Massimiliano d'Erme"

Article Synopsis
  • - Atopic dermatitis (AD) is a common chronic skin condition, but there is currently no effective way to predict which newborns are at risk for developing it.
  • - A study evaluated specific serological biomarkers in 40 newborns to see if they could predict the development of AD, using measurements from cord blood and skin assessments at various ages.
  • - Findings indicated that infants who developed AD showed significantly higher levels of certain biomarkers at birth, suggesting potential predictive indicators for the condition.
View Article and Find Full Text PDF

Atopic Dermatitis (AD) is the most prevalent inflammatory skin disorder resulting in an intense impact on patients quality of life. The aim of this study is to evaluate the clinical meaning of the DLQI scores documented between different phenotypes of AD patients under biologic therapy with Dupilumab. We conducted a retrospective analysis of 209 patients with AD treated with Dupilumab for 2 years.

View Article and Find Full Text PDF

Sentinel lymph node biopsy is a crucial step in the management of patients affected by melanoma. The decision whether to perform it or not is based on different histological parameters, but the mitotic rate is no longer considered a prognostic variable after the release of the 8th edition of the American Joint Committee on Cancer (AJCC) guidelines. Our objective was to investigate the risk factors that increase the chance for sentinel lymph node positivity in melanomas with a Breslow thickness of less than 2.

View Article and Find Full Text PDF

Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer that still has a poor prognosis. MCC incidence has increased in recent years worldwide. The aim of our study was to perform an epidemiological retrospective study and to evaluate the impact of MCC clinical and pathological features on overall survival (OS) in a specific geographical area.

View Article and Find Full Text PDF
Article Synopsis
  • Actinic keratosis (AK) is a precancerous skin lesion that can lead to invasive squamous cell carcinoma, affecting a significant portion of the global adult population.
  • Risk factors include advanced age, fair skin, and sun exposure, with treatments varying based on lesion characteristics and patient factors.
  • A study of 110 Italian dermatologists revealed that cryotherapy and photodynamic therapy are the most commonly used treatments, while adherence to therapy is vital for effective outcomes.
View Article and Find Full Text PDF

A very rare variant of mammary Paget disease (MPD) is the pigmented MPD, first described in 1956. It is very difficult to distinguish this variant from melanoma both clinically and dermoscopically. The diagnosis is confirmed by histopathology and immunohistochemistry.

View Article and Find Full Text PDF

Background: Atopic dermatitis (AD) in the elderly has been poorly investigated, although its incidence is gradually increasing mainly in industrialized countries. Age-specific factors in older patients must be considered when selecting treatment options.

Objectives: To evaluate the efficacy and tolerability of dupilumab in treating elderly patients with severe AD.

View Article and Find Full Text PDF

Purpose: This study was conducted to determine the difference in anatomo-pathological and prognostic features of cutaneous melanoma in children, adolescents and young adults.

Methods: This is a retrospective review on 383 young patients ≤ 39 years of age with cutaneous melanoma, in a period from 2006 to 2016 in Area Vasta Nord Ovest, Tuscany, Italy. We subdivided patients in three groups (children ≤ 14 years, adolescents 15-21 years, young adults 22-39 years).

View Article and Find Full Text PDF

Atopic dermatitis (AD) is among the most common inflammatory skin diseases in children and adults in industrialized countries. Up to one-third of adults (probably a smaller proportion in childhood) suffer from moderate-to-severe AD, whose recommended treatment is usually based on systemic therapies. The currently available therapeutics are limited, and AD management becomes challenging in most cases.

View Article and Find Full Text PDF